Eczema drug tested for power to soothe anxiety and depression
NCT ID NCT07467564
Summary
This study is checking if a medicine called dupilumab, already used for moderate-to-severe eczema, can also help improve anxiety and depression in people with this skin condition. It will observe about 184 patients from Gulf countries who are starting this treatment for 6 months. The main goal is to see if their mental health and quality of life get better while their eczema is being treated.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NMC Specialty Hospital LTD
RECRUITINGAbu Dhabi, United Arab Emirates
Conditions
Explore the condition pages connected to this study.